Dr Deininger on Long-Term Outcomes With Ponatinib in T315I-Mutant CP-CML | OncLive
Dr Deininger on Long-Term Outcomes With Ponatinib in T315I …
Jun 20, 2024
onclive.com
Managing T315I Mutations in CML: Second Line Treatment Options - Ponatinib & Asciminib | OncLive
Managing T315I Mutations in CML: Second Line Treatment Options - …
Dec 20, 2024
onclive.com
Ponatinib: Overview, Mechanism of Action & Clinical Trials | Takeda Oncology
4:38
Ponatinib: Overview, Mechanism of Action & Clinical Trials | Takeda O…
May 18, 2020
oncologymedinfo.com
Dr Deininger on Long-Term Outcomes With Ponatinib in T315I-Mutant CP-CML
2:32
Dr Deininger on Long-Term Outcomes With Ponatinib in T315I …
141 viewsJun 21, 2024
YouTubeOncLive
Case 2: Ponatinib for T315I-Mutated CML
5:07
Case 2: Ponatinib for T315I-Mutated CML
508 viewsJun 4, 2019
YouTubeTargeted Oncology
Resistance to Targeted-TKI Treatment in Patients With CML
6:51
Resistance to Targeted-TKI Treatment in Patients With CML
625 viewsJul 8, 2019
YouTubeTargeted Oncology
TKI chemotherapy and ponatinib improve survival outcomes in CML blast phase
5:47
TKI chemotherapy and ponatinib improve survival outcomes in CM…
2 views3 weeks ago
YouTubeecancer
2:23
5-year Data for Ponatinib in Pretreated CP-CML from the OPTI…
Jan 23, 2025
onclive.com
0:15
Ponatinib, rotating 3D model of antineoplastic agents, seamless lo…
Sep 10, 2024
AdobeСергей Шиманович
1:54
Targeting the T315I mutation with ponatinib to treat patients with R/…
669 viewsDec 20, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
24:30
Management of Thrombosis Risk with Ponatinib and other TKIs for …
1.4K viewsMay 15, 2015
YouTubeHMP Global
ASH 2025 Insights: Ponatinib vs. Imatinib in Combination With Che…
4 months ago
vumedi.com
Blinatumomab + Ponatinib for Adults With Newly Diagnosed Ph…
4 months ago
vumedi.com
Responder Analysis From the PhALLCON Trial: Ponatinib vs. Im…
116 viewsJun 24, 2024
vumedi.com
2:49
Outcomes of patients with CML-CP treated with ponatinib vs 2G-TKIs i…
336 viewsFeb 10, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
ASH 2025 Insights: 1st Results of the Ph3 GIMEMA ALL2820 Trial Co…
120 views5 months ago
vumedi.com
0:54
In the PhALLCON trial, laboratory evidence showed that the rate of …
1.3K viewsMay 10, 2024
FacebookJAMA
17:38
Debate: Chronic-Phase CML Patient Develops a T315I Mutation - Trans…
1.2K viewsJun 5, 2019
YouTubeHMP Education
[Hot Item] Ponatinib Intermediate CAS No.: 943320-61-4
2 months ago
made-in-china.com
4:44
Ponatinib in chronic-phase CML patients with prior second generat…
382 viewsDec 7, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:10
Recent Updates from the OPTIC Trial of Ponatinib in Resistant CML
468 views7 months ago
YouTubeFadi Haddad M.D.
2:51
The use of asciminib versus ponatinib for multiresistant CML
1.5K viewsOct 20, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:38
An update on the OPTIC study: adjusting the dose of ponatinib fo…
116 viewsSep 17, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:46
CML: Rationale for Mutation Testing and TKI Therapy
156 viewsDec 22, 2017
YouTubeTargeted Oncology
2:20
Dose modification of ponatinib in CP-CML: data from the PACE an…
84 viewsNov 2, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:08
Managing drug resistance in CP-CML with ponatinib and asciminib
206 viewsDec 13, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:43
Dosing strategy of ponatinib in CP-CML: insights from the OPTIC trial
119 viewsJun 2, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:17
Ponatinib versus ascimininib in the third-line treatment of CML
616 viewsOct 24, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:25
Dr. Hagop Kantarjian on Ponatinib as Frontline Therapy for Chronic …
18 views6 months ago
YouTubeAmerican Cancer Society Journals
1:04
ASH 2024: Bijal Shah, MD Presents on the Blinatumomab + Ponatinib …
145 viewsDec 11, 2024
YouTubeMoffitt Cancer Center
See more videos
Static thumbnail place holder